Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 164
10
Diseases
21
Unique genes
0.312
Avg. similarity score
B-cell lymphopenia
Most-connected disease (8 links)
Disease
Searched: Hypocellular bone marrow
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hypocellular bone marrow
B-cell lymphopenia
Digit abnormalities
MECOM-associated syndrome
Radioulnar synostosis with amegakaryocytic thrombocytopenia 2
Hypogammaglobulinemia
Radioulnar synostosis
Radioulnar synostosis with amegakaryocytic thrombocytopenia 1
Hyperpituitarism
Immunodeficiency 82 with systemic inflammation
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| B-cell lymphopenia | 8 | 8 | 1 |
| Digit abnormalities | 8 | 8 | 1 |
| Hypocellular bone marrow | 8 | 8 | 1 |
| MECOM-associated syndrome | 8 | 8 | 1 |
| Radioulnar synostosis with amegakaryocytic thrombocytopenia 2 | 7 | 7 | 1 |
| Hypogammaglobulinemia | 6 | 6 | 4 |
| Radioulnar synostosis | 5 | 5 | 3 |
| Radioulnar synostosis with amegakaryocytic thrombocytopenia 1 | 5 | 5 | 2 |
| Hyperpituitarism | 4 | 4 | 15 |
| Immunodeficiency 82 with systemic inflammation | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MECOM | 9 / 10 | B-cell lymphopenia, Digit abnormalities, Hyperpituitarism, Hypocellular bone marrow and 5 more |
| SYK | 2 / 10 | Hypogammaglobulinemia, Immunodeficiency 82 with systemic inflammation |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | Reactome | 2 / 23 | 49.7× | 7.21e-4 | 8.37e-3 ✓ sig. |
| Lysine degradation | KEGG | 2 / 63 | 18.2× | 5.33e-3 | 3.65e-2 ✓ sig. |
| PKMTs methylate histone lysines | Reactome | 2 / 71 | 16.1× | 6.73e-3 | 4.25e-2 ✓ sig. |
| Fc epsilon receptor (FCERI) signaling | Reactome | 1 / 6 | 95.3× | 1.04e-2 | 5.63e-2 |
| B cell receptor signaling pathway | KEGG | 2 / 91 | 12.6× | 1.09e-2 | 5.79e-2 |
| RUNX2 regulates bone development | Reactome | 1 / 7 | 81.7× | 1.22e-2 | 6.20e-2 |
| Hematopoietic cell lineage | KEGG | 2 / 100 | 11.4× | 1.30e-2 | 6.44e-2 |
| Conjugation of salicylate with glycine | Reactome | 1 / 8 | 71.5× | 1.39e-2 | 6.72e-2 |
| NF-kappa B signaling pathway | KEGG | 2 / 105 | 10.9× | 1.43e-2 | 6.83e-2 |
| Interleukin-2 signaling | Reactome | 1 / 12 | 47.7× | 2.08e-2 | 8.54e-2 |
| FCGR activation | Reactome | 1 / 12 | 47.7× | 2.08e-2 | 8.54e-2 |
| Osteoclast differentiation | KEGG | 2 / 142 | 8.1× | 2.52e-2 | 9.61e-2 |
| Role of LAT2/NTAL/LAB on calcium mobilization | Reactome | 1 / 15 | 38.1× | 2.59e-2 | 9.76e-2 |
| Role of phospholipids in phagocytosis | Reactome | 1 / 21 | 27.2× | 3.61e-2 | 1.18e-1 |
| Regulation of signaling by CBL | Reactome | 1 / 21 | 27.2× | 3.61e-2 | 1.18e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| response to estrogen | GO:0043627 | 3 / 49 | 54.5× | 2.18e-5 | 9.63e-4 ✓ sig. |
| embryonic skeletal joint morphogenesis | GO:0060272 | 2 / 11 | 162× | 6.58e-5 | 2.22e-3 ✓ sig. |
| embryonic forelimb morphogenesis | GO:0035115 | 2 / 33 | 53.9× | 6.22e-4 | 1.08e-2 ✓ sig. |
| metanephros development | GO:0001656 | 2 / 38 | 46.8× | 8.25e-4 | 1.28e-2 ✓ sig. |
| daunorubicin transport | GO:0043215 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |
| terpenoid transport | GO:0046865 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |
| cellular response to nonylphenol | GO:1904148 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |
| positive regulation of establishment of Sertoli cell barrier | GO:1904446 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |
| cellular response to borneol | GO:1905231 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |
| response to codeine | GO:1905233 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |
| response to quercetin | GO:1905235 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |
| positive regulation of response to drug | GO:2001025 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |
| positive regulation of interleukin-1-mediated signaling pathway | GO:2000661 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |
| serotonin secretion | GO:0001820 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |
| positive regulation of interleukin-3 production | GO:0032752 | 1 / 1 | 890× | 1.12e-3 | 1.53e-2 ✓ sig. |